Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes | MicrobiomeTrials← Back to trialsNCT07291609
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-01-01Est. Completion: 2026-12-31
Enrollment target: 120 participants Locations- Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy., Caserta, Italy
- Cardiovascular Division, Morgagni-Pierantoni University Hospital, Forlì, Italy., Forlì, Italy
- Centro Cardiologico Monzino, Milan, Italy
- Department of Advanced Medical and Surgical Sciences, University of Campania-Luigi Vanvitelli, Naples, Italy., Naples, Italy
- Sant'Andrea University Hospital, Roma, Italy
- Azienda Ospedaliera Integrata Verona, Italy, Verona, Italy
Other microbiome trials you might be interested in
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, SpainEst. completion Oct 2, 2026
Heart Failure
Background:
More than 6.5 million people in the United States live with heart failure (HF), and more than a million new…
Falls Church, United StatesCompleted Apr 30, 2028
Acute Respiratory Distress Syndrome (ARDS)s100bMechanical PowerVentilator Induced Lung InjuryTranspulmonary Pressure
Acute respiratory distress syndrome (ARDS) is characterized by pathological pulmonary edema caused by direct or indirect…
Multiple LocationsEst. completion Oct 23, 2028